These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 28892121)

  • 21. Statins After Myocardial Infarction in the Oldest: A Cohort Study in the Clinical Practice Research Datalink Database.
    Lefeber GJ; Koek HL; Souverein PC; Bouvy ML; de Boer A; Knol W
    J Am Geriatr Soc; 2020 Feb; 68(2):329-336. PubMed ID: 31647578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials.
    Mora S; Glynn RJ; Hsia J; MacFadyen JG; Genest J; Ridker PM
    Circulation; 2010 Mar; 121(9):1069-77. PubMed ID: 20176986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Asymptomatic individuals with a positive family history for premature coronary artery disease and elevated coronary calcium scores benefit from statin treatment: a post hoc analysis from the St. Francis Heart Study.
    Mulders TA; Sivapalaratnam S; Stroes ES; Kastelein JJ; Guerci AD; Pinto-Sietsma SJ
    JACC Cardiovasc Imaging; 2012 Mar; 5(3):252-60. PubMed ID: 22421169
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of statin use for the primary prevention of cardiovascular disease among older adults: a cautionary tale concerning target trials emulation.
    Mésidor M; Sirois C; Guertin JR; Schnitzer ME; Candas B; Blais C; Cossette B; Poirier P; Brophy JM; Lix L; Tadrous M; Diop A; Hamel D; Talbot D
    J Clin Epidemiol; 2024 Apr; 168():111284. PubMed ID: 38367659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Statin Therapy on Mortality in Older Adults Hospitalized with Coronary Artery Disease: A Propensity-Adjusted Analysis.
    Rothschild DP; Novak E; Rich MW
    J Am Geriatr Soc; 2016 Jul; 64(7):1475-9. PubMed ID: 27295083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New statin use, mortality, and first cardiovascular events in older US Veterans by frailty status.
    Orkaby AR; Lu B; Ho YL; Treu T; Galloway A; Wilson PWF; Cho K; Gaziano JM; Alexander KP; Gagnon DR; Djousse L; Forman DE; Driver JA
    J Am Geriatr Soc; 2024 Feb; 72(2):410-422. PubMed ID: 38055194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HMG CoA reductase inhibitors (statins) for dialysis patients.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Nigwekar SU; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD004289. PubMed ID: 24022428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statins for primary prevention in adults aged 75 years and older: A nationwide population-based case-control study.
    Jun JE; Cho IJ; Han K; Jeong IK; Ahn KJ; Chung HY; Hwang YC
    Atherosclerosis; 2019 Apr; 283():28-34. PubMed ID: 30772771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The beneficial effects of statins in patients undergoing hemodialysis.
    Huang CC; Chan WL; Chen YC; Chen TJ; Chung CM; Huang PH; Lin SJ; Chen JW; Leu HB
    Int J Cardiol; 2013 Oct; 168(4):4155-9. PubMed ID: 23928338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statins for the primary prevention of cardiovascular disease.
    Taylor F; Huffman MD; Macedo AF; Moore TH; Burke M; Davey Smith G; Ward K; Ebrahim S
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004816. PubMed ID: 23440795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association Between Achieved Low-Density Lipoprotein Levels and Major Adverse Cardiac Events in Patients With Stable Ischemic Heart Disease Taking Statin Treatment.
    Leibowitz M; Karpati T; Cohen-Stavi CJ; Feldman BS; Hoshen M; Bitterman H; Suissa S; Balicer RD
    JAMA Intern Med; 2016 Aug; 176(8):1105-13. PubMed ID: 27322095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study.
    Ramos R; Comas-Cufí M; Martí-Lluch R; Balló E; Ponjoan A; Alves-Cabratosa L; Blanch J; Marrugat J; Elosua R; Grau M; Elosua-Bayes M; García-Ortiz L; Garcia-Gil M
    BMJ; 2018 Sep; 362():k3359. PubMed ID: 30185425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and Effectiveness of Statins for Prevention of Recurrent Myocardial Infarction in 12 156 Typical Older Patients: A Quasi-Experimental Study.
    Ble A; Hughes PM; Delgado J; Masoli JA; Bowman K; Zirk-Sadowski J; Mujica Mota RE; Henley WE; Melzer D
    J Gerontol A Biol Sci Med Sci; 2017 Feb; 72(2):243-250. PubMed ID: 27146371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid-lowering drug use and cardiovascular events after myocardial infarction.
    Klungel OH; Heckbert SR; de Boer A; Leufkens HG; Sullivan SD; Fishman PA; Veenstra DL; Psaty BM
    Ann Pharmacother; 2002 May; 36(5):751-7. PubMed ID: 11978147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smoking cessation for secondary prevention of cardiovascular disease.
    Wu AD; Lindson N; Hartmann-Boyce J; Wahedi A; Hajizadeh A; Theodoulou A; Thomas ET; Lee C; Aveyard P
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD014936. PubMed ID: 35938889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statins for Prevention of Cardiovascular Events in a Low-Risk Population With Low Ankle Brachial Index.
    Ramos R; García-Gil M; Comas-Cufí M; Quesada M; Marrugat J; Elosua R; Sala J; Grau M; Martí R; Ponjoan A; Alves-Cabratosa L; Blanch J; Bolíbar B
    J Am Coll Cardiol; 2016 Feb; 67(6):630-640. PubMed ID: 26868687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Number needed to treat with rosuvastatin to prevent first cardiovascular events and death among men and women with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER).
    Ridker PM; MacFadyen JG; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Koenig W; Libby P; Lorenzatti AJ; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ;
    Circ Cardiovasc Qual Outcomes; 2009 Nov; 2(6):616-23. PubMed ID: 20031900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statin treatment after a recent TIA or stroke: is effectiveness shown in randomized clinical trials also observed in everyday clinical practice?
    Lingsma HF; Steyerberg EW; Scholte op Reimer WJ; van Domburg R; Dippel DW;
    Acta Neurol Scand; 2010 Jul; 122(1):15-20. PubMed ID: 20047571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statins are associated with a large reduction in all-cause mortality in women from a cardiac outpatient population.
    Bots SH; Onland-Moret NC; Jancev M; Hollander M; Tulevski II; Hofstra L; Somsen GA; den Ruijter HM
    Open Heart; 2022 Apr; 9(1):. PubMed ID: 35444049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low use of statins for secondary prevention in primary care: a survey in a northern Swedish population.
    Nilsson G; Samuelsson E; Söderström L; Mooe T
    BMC Fam Pract; 2016 Aug; 17(1):110. PubMed ID: 27515746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.